182 related articles for article (PubMed ID: 18996915)
1. The Drosophila homologue of the Angelman syndrome ubiquitin ligase regulates the formation of terminal dendritic branches.
Lu Y; Wang F; Li Y; Ferris J; Lee JA; Gao FB
Hum Mol Genet; 2009 Feb; 18(3):454-62. PubMed ID: 18996915
[TBL] [Abstract][Full Text] [Related]
2. A Drosophila model for Angelman syndrome.
Wu Y; Bolduc FV; Bell K; Tully T; Fang Y; Sehgal A; Fischer JA
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12399-404. PubMed ID: 18701717
[TBL] [Abstract][Full Text] [Related]
3. Proteomic profiling in Drosophila reveals potential Dube3a regulation of the actin cytoskeleton and neuronal homeostasis.
Jensen L; Farook MF; Reiter LT
PLoS One; 2013; 8(4):e61952. PubMed ID: 23626758
[TBL] [Abstract][Full Text] [Related]
4. The E3 ligase ube3a is required for learning in Drosophila melanogaster.
Chakraborty M; Paul BK; Nayak T; Das A; Jana NR; Bhutani S
Biochem Biophys Res Commun; 2015 Jun; 462(1):71-7. PubMed ID: 25935478
[TBL] [Abstract][Full Text] [Related]
5. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
6. The Drosophila melanogaster homolog of UBE3A is not imprinted in neurons.
Hope KA; LeDoux MS; Reiter LT
Epigenetics; 2016 Sep; 11(9):637-642. PubMed ID: 27599063
[TBL] [Abstract][Full Text] [Related]
7. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Reiter LT; Seagroves TN; Bowers M; Bier E
Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
[TBL] [Abstract][Full Text] [Related]
8. Drosophila Ube3a regulates monoamine synthesis by increasing GTP cyclohydrolase I activity via a non-ubiquitin ligase mechanism.
Ferdousy F; Bodeen W; Summers K; Doherty O; Wright O; Elsisi N; Hilliard G; O'Donnell JM; Reiter LT
Neurobiol Dis; 2011 Mar; 41(3):669-77. PubMed ID: 21147225
[TBL] [Abstract][Full Text] [Related]
9. Glial overexpression of Dube3a causes seizures and synaptic impairments in Drosophila concomitant with down regulation of the Na
Hope KA; LeDoux MS; Reiter LT
Neurobiol Dis; 2017 Dec; 108():238-248. PubMed ID: 28888970
[TBL] [Abstract][Full Text] [Related]
10. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
[TBL] [Abstract][Full Text] [Related]
11. Angelman Syndrome Protein Ube3a Regulates Synaptic Growth and Endocytosis by Inhibiting BMP Signaling in Drosophila.
Li W; Yao A; Zhi H; Kaur K; Zhu YC; Jia M; Zhao H; Wang Q; Jin S; Zhao G; Xiong ZQ; Zhang YQ
PLoS Genet; 2016 May; 12(5):e1006062. PubMed ID: 27232889
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic Ube3a E3 ligase promotes synapse elimination through down-regulation of BMP signaling.
Furusawa K; Ishii K; Tsuji M; Tokumitsu N; Hasegawa E; Emoto K
Science; 2023 Sep; 381(6663):1197-1205. PubMed ID: 37708280
[TBL] [Abstract][Full Text] [Related]
14. A genome-wide enhancer/suppressor screen for Dube3a interacting genes in Drosophila melanogaster.
Hope KA; McGinn A; Reiter LT
Sci Rep; 2019 Feb; 9(1):2382. PubMed ID: 30787400
[TBL] [Abstract][Full Text] [Related]
15. Drosophila UBE3A regulates satiety signaling through the Piezo mechanosensitive ion channel.
Geier B; Neely L; Coronado E; Reiter LT
Res Sq; 2023 Jul; ():. PubMed ID: 37461494
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic and proteomic profiling of glial versus neuronal Dube3a overexpression reveals common molecular changes in gliopathic epilepsies.
Hope KA; Johnson D; Miller PW; Lopez-Ferrer D; Kakhniashvili D; Reiter LT
Neurobiol Dis; 2020 Jul; 141():104879. PubMed ID: 32344153
[TBL] [Abstract][Full Text] [Related]
18. Angelman syndrome-associated point mutations in the Zn
Kühnle S; Martínez-Noël G; Leclere F; Hayes SD; Harper JW; Howley PM
J Biol Chem; 2018 Nov; 293(47):18387-18399. PubMed ID: 30257870
[TBL] [Abstract][Full Text] [Related]
19. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
[TBL] [Abstract][Full Text] [Related]
20. HAP1 is an in vivo UBE3A target that augments autophagy in a mouse model of Angelman syndrome.
Wang T; Wang J; Wang J; Mao L; Tang B; Vanderklish PW; Liao X; Xiong ZQ; Liao L
Neurobiol Dis; 2019 Dec; 132():104585. PubMed ID: 31445164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
